261 related articles for article (PubMed ID: 22154100)
1. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):706-10. PubMed ID: 21885261
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis.
Tomoda K; Watanabe A; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Sep; 97():84-9. PubMed ID: 22609586
[TBL] [Abstract][Full Text] [Related]
4. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles.
Takeuchi I; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():312-317. PubMed ID: 28858661
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis.
Takeuchi I; Fukuda K; Kobayashi S; Makino K
Biomed Mater Eng; 2016 Nov; 27(5):475-483. PubMed ID: 27885995
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
7. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis.
Takeuchi I; Kobayashi S; Hida Y; Makino K
Colloids Surf B Biointerfaces; 2017 Jul; 155():35-40. PubMed ID: 28391082
[TBL] [Abstract][Full Text] [Related]
9. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
10. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
13. Needle-free transdermal delivery using PLGA nanoparticles: effect of particle size, injection pressure and syringe orifice diameter.
Park CH; Tijing LD; Kim CS; Lee KM
Colloids Surf B Biointerfaces; 2014 Nov; 123():710-5. PubMed ID: 25456991
[TBL] [Abstract][Full Text] [Related]
14. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system.
Zakeri-Milani P; Loveymi BD; Jelvehgari M; Valizadeh H
Colloids Surf B Biointerfaces; 2013 Mar; 103():174-81. PubMed ID: 23201735
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
16. Delivery of polymeric particles into skin using needle-free liquid jet injectors.
Michinaka Y; Mitragotri S
J Control Release; 2011 Aug; 153(3):249-54. PubMed ID: 21457734
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
[TBL] [Abstract][Full Text] [Related]
18. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.
Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A
J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
20. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]